Skip to main content

RxHighlights

A monthly overview of treatment guidelines, important literature and key issues influencing today’s pharmacy and health care environment.

May 2025

Core topics in this month’s edition include:

  • mNEXSPIKE® (COVID-19 vaccine, mRNA) – New drug approval
  • Jivi® (antihemophilic factor [recombinant], PEGylated-aucl) – Expanded indication
  • Brekiya® (dihydroergotamine) – New drug approval

Download

Rx navigation